Community pharmacists' therapeutic recommendations for heavy flow, androgen excess, fragility fractures and night sweats in menstruating women
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, 143(2), 88-95.e2
Abstract
Physicians and menstruating women often ask pharmacists for recommendations about menstrual cycle–related problems. Progesterone and medroxyprogesterone may provide physiology-based treatment, but official indications in menstruating women in Canada are minimal.
To describe pharmacists' responses to vignette-based questions about the treatment of common clinical problems in menstruating women and review evidence-based therapies.
A pharmacist interviewer administered an 11-item questionnaire to a random sample of community pharmacists. Questions were based on clinical vignettes in adolescent, pre- and perimenopausal women and related to heavy flow, polycystic ovary syndrome, premenopausal osteoporosis, perimenopausal night sweats and side effects/contraindications for estrogens and progesterone/progestins.
The participation rate was 58%, including equal numbers of male and female pharmacists. Seventy-two percent indicated that they would treat menorrhagia in an anemic 13-year-old with oral contraceptives — 21% would recommend ibuprofen and 86% iron. Half recommended that a 35-year-old smoker with heavy flow and acne stop oral contraceptives, but the other 50% recommended a switch to an oral contraceptive with cyproterone. For premenopausal osteoporosis, the majority recommended calcium and vitamin D, but 53% endorsed oral contraceptives — only 7% suggested cyclic medroxyprogesterone. For night sweats, the majority recommended progesterone/progestin in a regularly menstruating 42-year-old woman. Estrogens are contraindicated with past thrombosis and/or breast cancer family history, and they could cause nausea; 50% of pharmacists also attributed these adverse effects to progesterone/progestins.
Community pharmacists vary widely in their treatment choices for common pre- and perimenopausal women's menstrual cycle–related problems. The evidence in support of most recommendations is minimal or lacking.
Topics
Cite this article
Marks, M., Hitchcock, C. L., Sathi, P., & Prior, J. C. (1900). Community Pharmacists' Therapeutic Recommendations for Menstruating Women. *Canadian Pharmacists Journal / Revue des Pharmaciens du Canada*, *143*(2), 88-95.e2. https://doi.org/10.3821/1913-701X-143.2.88
Marks M, Hitchcock CL, Sathi P, Prior JC. Community Pharmacists' Therapeutic Recommendations for Menstruating Women. Can Pharm J. 1900;143(2):88-95.e2. doi:10.3821/1913-701X-143.2.88
Marks, M., et al. "Community Pharmacists' Therapeutic Recommendations for Menstruating Women." *Canadian Pharmacists Journal / Revue des Pharmaciens du Canada*, vol. 143, no. 2, 1900, pp. 88-95.e2.